Publicacións nas que colabora con Carlos García Girón (6)

2021

  1. First-Line Biological Agents Plus Chemotherapy in Older Patients with Metastatic Colorectal Cancer: A Retrospective Pooled Analysis

    Drugs and Aging, Vol. 38, Núm. 3, pp. 219-231

2015

  1. Correlation of hypertension and proteinuria with outcome in elderly bevacizumab-treated patients with metastatic colorectal cancer

    PLoS ONE, Vol. 10, Núm. 1

2014

  1. First-line bevacizumab and capecitabine-oxaliplatin in elderly patients with mCRC: GEMCAD phase II BECOX study

    British Journal of Cancer, Vol. 111, Núm. 2, pp. 241-248

  2. Phase II study of bevacizumab, capecitabine, and oxaliplatin followed by bevacizumab plus erlotinib as first-line therapy in metastatic colorectal cancer

    Oncology Research, Vol. 21, Núm. 4, pp. 181-191

2013

  1. Phase ii study of irinotecan in combination with capecitabine on a 3-weekly schedule as first-line chemotherapy for patients with metastatic or locally advanced colorectal cancer

    Journal of Analytical Oncology, Vol. 2, Núm. 3, pp. 151-159

2010

  1. Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer

    British Journal of Cancer, Vol. 102, Núm. 10, pp. 1468-1473